Tirofiban therapy does not increase the risk of hemorrhage after emergency coronary surgery.
Genoni
M
M
Department of Heart Surgery, Triemli City Hospital, Zurich, Switzerland. michele.genoni@triemli.stzh.ch
Zeller
D
D
Bertel
O
O
Maloigne
M
M
Turina
M
M
D001777:Blood Coagulation / Q000187:drug effects; D001803:Blood Transfusion; D003327:Coronary Disease / Q000097:blood / Q000601:surgery*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D004630:Emergencies; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced* / Q000628:therapy; D006801:Humans; D007262:Infusions, Intravenous; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D014443:Tyrosine; D000077466:Tirofiban